Argent Biopharma Ltd (ASX: RGT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Argent Biopharma Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.14 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 54.27 million
Earnings per share -0.474
Dividend per share N/A
Year To Date Return -67.37%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Argent Biopharma Ltd (ASX: RGT)
    Latest News

    Lab worker puts hands in the air and dances around
    Healthcare Shares

    The MGC Pharmaceuticals (ASX:MXC) share price soared 20% today. Here's why

    The cannabis company's shares finished the week on a high note...

    Read more »

    A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital
    Healthcare Shares

    MGC Pharmaceuticals (ASX:MXC) share price climbs on study approval

    The Israeli Ministry of Health has approved a dosing study of a drug candidate. Here are the details

    Read more »

    A group of science or medical professionals cheering good news in the lab.
    Healthcare Shares

    Why the MGC Pharmaceuticals (ASX:MXC) share price is leaping 5%

    MGC Pharma shares are talking the talk today after a key update. Here's what we know.

    Read more »

    Falling cannabis asx share price represented by cannabis leaves on a declining line graph
    Share Market News

    What's going wrong for ASX cannabis shares lately?

    Why Aussie cannabis companies are worth watching right now...

    Read more »

    Cannabis from the earth in the hands
    Share Gainers

    MGC Pharma (ASX:MXC) share price jumps 11% on UK approval

    This cannabis share is smoking the market today...

    Read more »

    A businessman leaps in the air outside a city building in the CBD.
    Share Market News

    MGC Pharmaceuticals (ASX:MXC) share price rockets 40% on supply deal

    A new US supply and distribution deal has seen shares in the pharma company soar

    Read more »

    Three pills with faces showing sad to happy, indicating a rising share price for an ASX pharmaceutical company
    Healthcare Shares

    The MGC Pharmaceuticals (ASX:MXC) share price is on a roll today. Here's why

    The MGC Pharmaceuticals (ASX: MXC) share price is up 3.4% after the company shared news of a $1 million order.

    Read more »

    A graphic showing a rising share price in medical cannabis shares
    Share Gainers

    Why the MGC Pharma (ASX:MXC) share price has rocketed 9%

    The MGC Pharma Ltd (ASX: MGC) share price is rocketing higher amid a broader rebound and North American product update…

    Read more »

    The last piece of the jigsaw being fitted, indicating good news for a share price on merger or acquisition
    Healthcare Shares

    Why the MGC Pharmaceuticals (ASX:MXC) share price is up 5% today

    The MGC Pharmaceuticals (ASX: MXC) share price is soaring with news the company will acquire a clinical research company.

    Read more »

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price
    Share Market News

    Why the MGC Pharma (ASX:MXC) share price is zooming 13% higher today

    The MGC Pharma (ASX: MXC) share price is up 13% in morning trade. We look at the latest from the…

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Share Market News

    Why the MGC Pharmaceuticals (ASX:MXC) share price is jumping 8%

    The MGC Pharmaceuticals (ASX:MXC) share price is surging after the company's drug was passed by two ethics committees. Here's the…

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Up 310% the MGC Pharma (ASX:MXC) share price is gaining again today

    The MGC Pharma share price is gaining today, up 3% in late morning trade. We take a look at what's…

    Read more »

    RGT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Argent Biopharma Ltd

    MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. Its Endocannabinoid system covers all cells and nerves; it is the messenger of information flowing between immune system and the central nervous system. The company was founded by Nativ Segev on October 21, 2005 and is headquartered in Perth, Australia.

    RGT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    24 Dec 2024 $0.15 $-0.01 -6.45% 4,289 $0.16 $0.16 $0.15
    23 Dec 2024 $0.16 $0.00 0.00% 155 $0.16 $0.16 $0.16
    20 Dec 2024 $0.16 $-0.02 -11.76% 56,564 $0.16 $0.16 $0.16
    19 Dec 2024 $0.17 $0.00 0.00% 2,788 $0.17 $0.17 $0.17
    18 Dec 2024 $0.17 $0.00 0.00% 85,389 $0.17 $0.18 $0.17
    17 Dec 2024 $0.17 $-0.01 -5.56% 37,648 $0.18 $0.18 $0.17
    16 Dec 2024 $0.18 $0.01 5.71% 33,084 $0.18 $0.18 $0.18
    13 Dec 2024 $0.18 $-0.02 -10.26% 63,991 $0.19 $0.19 $0.18
    12 Dec 2024 $0.20 $-0.01 -5.00% 21,673 $0.20 $0.20 $0.19
    11 Dec 2024 $0.20 $0.01 5.26% 4,935 $0.20 $0.20 $0.20
    10 Dec 2024 $0.19 $-0.01 -5.00% 13,544 $0.20 $0.20 $0.19
    09 Dec 2024 $0.20 $0.00 0.00% 1,339 $0.20 $0.20 $0.20
    06 Dec 2024 $0.21 $-0.02 -9.09% 146 $0.21 $0.21 $0.21
    05 Dec 2024 $0.22 $0.01 4.65% 2,461 $0.22 $0.23 $0.22
    04 Dec 2024 $0.22 $-0.03 -12.50% 3,863 $0.22 $0.22 $0.21
    03 Dec 2024 $0.24 $-0.01 -4.00% 2,640 $0.24 $0.24 $0.24
    02 Dec 2024 $0.25 $-0.02 -7.41% 8,705 $0.27 $0.27 $0.25
    29 Nov 2024 $0.27 $0.02 8.00% 2,100 $0.25 $0.27 $0.25
    28 Nov 2024 $0.25 $0.00 0.00% 6,220 $0.26 $0.26 $0.25
    27 Nov 2024 $0.25 $0.01 4.17% 19,907 $0.26 $0.26 $0.25

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    15 Oct 2024 Roby Zomer Buy 4,000,000 $1,640,000
    As advised by the company.
    10 Sep 2024 Roby Zomer Buy 1,258,500 $503,400
    Off-market trade.
    28 Mar 2024 Layton Mills Issued 120,000 $49,200
    Issue of options.
    28 Mar 2024 Daniel Robinson Issued 120,000 $49,200
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Layton Patrick Mills Non-Executive Director Jun 2023
    Mr. Mills is an experienced life-sciences executive, having worked in the biotechnology and life sciences industries for over 15 years, developing experience across human and animal health in pharmaceutical and consumer healthcare. Mr Mills is also the founder and Managing Director of Subgenix Lifesciences, an early-stage biotechnology Company using conventional drug development strategies to unlock the broader therapeutic potential of psychedelic compounds for rare and underserved health needs. He has international business experience having been involved in corporate business activities across Europe, Asia and North America, including government-led trade incentives with the Canberra Business Chamber.
    Mr Brett Anthony Mitchell Executive ChairmanExecutive Director Apr 2013
    Mr Mitchell has over 25 years of experience in the venture capital, equity capital markets, technology and resources sectors. He has been involved in the founding, financing and management of both private and publicly listed companies, and was instrumental in the successful LSE listing for MGC Pharma in February 2021.
    Mr Daniel Robinson Non-Executive Director Dec 2023
    Mr Robinson has been appointed as a Non-Executive Director of the Company effective immediately. Mr Robinson has over 20 years of experience in a broad range of corporate roles across stockbroking, corporate advisory, investor relations and governance. He is an experienced Company Secretary and Director of both private and listed companies. Additionally, Mr Robinson is a Member of the Australian Institute of Company Directors.
    Mr Nativ Segev Non-Executive Director Feb 2016
    Mr Segev has over 10 years of experience in implementation, legislation and lobbying in the global Medical Cannabis industry, combined with over 15 years of experience in diverse executive roles.
    Mr Roby Reuven Zomer Chief Executive OfficerManaging Director Feb 2016
    Mr Zomer is an executive with experience in the biopharmaceutical and biotech industries. As the CEO of the company, Roby has demonstrated has driven strategic growth, managed financial operations, and ensured compliance with industry-specific standards. He also served as the Chairman of the Board for Graft Polymer, overseeing the implementation of advanced polymer solutions in the Biotech, Automotive and Recycling sectors. Roby's entrepreneurial background includes founding and leading Green City Urban Recycling, a pioneering Israeli company focused on biofuel production. His innovative work in this field contributed to national energy independence initiatives and led to the company's acquisition by Rafael Advanced Defense Systems. With an industrial engineering and management foundation, Roby Zomer brings a blend of technical and strategic skills to his professional endeavors.
    Mr Rowan Harland Company Secretary Mar 2023
    -
    Rowan Harland Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Oak Capital Partners Llc 8,370,718 17.29%
    Group Capital Llc 3,913,812 8.09%
    David Safren 3,405,016 7.03%
    Citicorp Nominees Pty Limited 2,301,084 4.75%
    Shlomie Bierman 2,230,874 4.61%
    Computershare Clearing Pty Ltd <Ccnl Di A/C> 2,099,936 4.34%
    Isamar Margareten 1,956,906 4.04%
    Mr Shachar Shimony 1,933,000 3.99%
    Yaakov Safren 1,643,802 3.40%
    Jacob Goldstein 1,623,072 3.35%
    Yoram Drucker 1,604,664 3.32%
    Yosef Safren 1,565,526 3.23%
    Shalom Safren 1,448,112 2.99%
    Bioheka Limited 1,258,500 2.60%
    Mrs Yifat Steuer 1,117,194 2.31%
    Eliron Yaron 750,000 1.55%
    A1 Invest Llc 625,000 1.29%
    Mr Itay David Nissim 600,000 1.24%
    Mr Amir Polak 592,626 1.22%
    Joseph Schwartz 547,934 1.14%

    Profile

    since

    Note